Clinical Trial Update: Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a Helicobacter pylori eradication therapy individualized by 23S rRNA mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Hamamatsu University | Conditions: H. Pylori Infection | Phase 2 | Status: UNKNOWN